<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Technetium Tc-99m labeled carbon: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Technetium Tc-99m labeled carbon: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Technetium Tc-99m labeled carbon: Drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_pediatric" data-topicid="143212" href="/d/html/143212.html" rel="external">see "Technetium Tc-99m labeled carbon: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F58703591"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Radiopharmaceutical</li></ul></div>
<div class="block doa drugH1Div" id="F58745619"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a242dd7a-63e5-444d-b313-c1b0fb21c573">Diagnostic imaging</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diagnostic imaging: Inhalation:</b> Load 10.8 to 27 mCi (400 to 1,000 MBq) of sodium pertechnetate Tc 99m into the technetium Tc 99m-labeled carbon crucible to achieve a lung count rate of 1,500 to 2,500 counts per second at the end of the last respiration; discontinue technetium Tc 99m-labeled carbon aerosol once achieved.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F58745621"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F58745622"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F58745620"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F58753904"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="143212" href="/d/html/143212.html" rel="external">see "Technetium Tc-99m labeled carbon: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a242dd7a-63e5-444d-b313-c1b0fb21c573">Diagnostic imaging</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Diagnostic imaging:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> The radioactivity needed for pediatric patients is based on body weight and is a fraction of what is needed for adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥6 years and Adolescents: Inhalation: Load a sufficient amount per the Crucible Loading Activity of Sodium Pertechnetate Tc 99m Injection table into the Technegas Crucible to achieve technetium Tc-99m labeled carbon crucible activity to achieve a lung count rate of 500 to 1,000 counts per second (cps) at the end of the last respiration; discontinue technetium Tc 99m-labeled carbon aerosol once achieved.</p>
<table border="1" frame="border" rules="all" style="margin-left:6em;">
<caption style="text-align:left;">
<b>Crucible Loading Activity of Sodium Pertechnetate Tc 99m Injectio</b>n for 500 to 1,000 cps</caption>
<colgroup><col align="left"/>
<col align="left"/>
</colgroup><thead valign="top">
<tr>
<th align="left">
<p style="text-indent:0em;">
<b>Weight</b></p></th>
<th align="left">
<p style="text-indent:0em;">
<b>Crucible loading activity</b></p></th></tr></thead>
<tbody valign="top">
<tr>
<td align="left">
<p style="text-indent:0em;">10 kg</p></td>
<td align="left">
<p style="text-indent:0em;">133 MBq (3.6 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">12 kg</p></td>
<td align="left">
<p style="text-indent:0em;">154 MBq (4.2 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">14 kg</p></td>
<td align="left">
<p style="text-indent:0em;">175 MBq (4.7 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">16 kg</p></td>
<td align="left">
<p style="text-indent:0em;">196 MBq (5.3 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">18 kg</p></td>
<td align="left">
<p style="text-indent:0em;">217 MBq (5.9 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">20 kg</p></td>
<td align="left">
<p style="text-indent:0em;">238 MBq (6.4 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">22 kg</p></td>
<td align="left">
<p style="text-indent:0em;">259 MBq (7 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">24 kg</p></td>
<td align="left">
<p style="text-indent:0em;">270 MBq (7.6 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">26 kg</p></td>
<td align="left">
<p style="text-indent:0em;">301 MBq (8.1 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">28 kg</p></td>
<td align="left">
<p style="text-indent:0em;">315 MBq (8.5 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">30 kg</p></td>
<td align="left">
<p style="text-indent:0em;">336 MBq (9.1 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">32 kg</p></td>
<td align="left">
<p style="text-indent:0em;">357 MBq (9.7 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">34 kg</p></td>
<td align="left">
<p style="text-indent:0em;">378 MBq (10 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">36 kg</p></td>
<td align="left">
<p style="text-indent:0em;">392 MBq (11 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">38 kg</p></td>
<td align="left">
<p style="text-indent:0em;">413 MBq (11 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">40 kg</p></td>
<td align="left">
<p style="text-indent:0em;">434 MBq (12 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">42 kg</p></td>
<td align="left">
<p style="text-indent:0em;">448 MBq (12 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">44 kg</p></td>
<td align="left">
<p style="text-indent:0em;">469 MBq (13 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">46 kg</p></td>
<td align="left">
<p style="text-indent:0em;">490 MBq (13 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">48 kg</p></td>
<td align="left">
<p style="text-indent:0em;">504 MBq (14 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">50 kg</p></td>
<td align="left">
<p style="text-indent:0em;">525 MBq (14 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">52 to 54 kg</p></td>
<td align="left">
<p style="text-indent:0em;">553 MBq (15 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">56 to 58 kg</p></td>
<td align="left">
<p style="text-indent:0em;">588 MBq (16 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">60 to 62 kg</p></td>
<td align="left">
<p style="text-indent:0em;">623 MBq (17 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">64 to 66 kg</p></td>
<td align="left">
<p style="text-indent:0em;">658 MBq (18 mCi)</p></td></tr>
<tr>
<td align="left">
<p style="text-indent:0em;">68 kg</p></td>
<td align="left">
<p style="text-indent:0em;">686 MBq (19 mCi)</p></td></tr></tbody></table></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F58754046"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F58754047"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F58721331"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Reported adverse reactions are for adults.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Respiratory: Oxygen saturation decreased (oxygen saturation &lt;90%: 68%; oxygen saturation &lt;85%: 39%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Respiratory: Hypoxia (1%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Dysgeusia</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Cough, dyspnea, respiratory congestion, throat irritation</p></div>
<div class="block coi drugH1Div" id="F58703594"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">There are no contraindications listed in the manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F58745614"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Bronchospasm: May result in acute bronchoconstriction, especially in patients with heightened bronchoreactivity (eg, asthma, other lung or allergic disorders).</p>
<p style="text-indent:-2em;margin-left:4em;">• Radiation accumulation: Technetium Tc 99m-labeled carbon administration contributes to the patient's overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk for cancer. Ensure safe handling to minimize radiation exposure to the patient and health care providers.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Disease-related concerns:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Respiratory disease: Patients with respiratory disease may be at increased risk due to decreases in oxygen saturation during or after treatment; supplemental oxygen or interruption of administration may be needed.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Special populations:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and health care personnel. Use only under supervision of individuals with experience/training in the handling of radioactive materials approved by the applicable regulatory authority. <b>Note:</b> Contents of kit are not radioactive; however, adequate shielding is required after addition of radioactive material.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: If clinically indicated, allow patients to breathe room air throughout procedure and consider administration of supplemental oxygen before or during the procedure.</p></div>
<div class="block prod-avail drugH1Div" id="F58703589"><span class="drugH1">Product Availability</span>
<p style="text-indent:0em;display:inline">Technegas: FDA approved October 2023; availability anticipated in 2023.</p></div>
<div class="block adm drugH1Div" id="F58745623"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Inhalation:</b> For inhalation use with an approved radionuclide rebreathing system for technetium Tc 99m-labeled carbon aerosol (eg, patient administration set from manufacturer) that connects to the Technegas Plus System. Add sodium pertechnetate Tc 99m injection into the technetium Tc 99m-labeled carbon crucible. Administer while patient is in the supine position. It is recommended to have patients inhale the aerosol through the mouthpiece by slow, deep breathing from the residual functional capacity (end of calm expiration) followed by a 5-second breath-hold; patients unable to hold their breath may breathe normally with deep inhalations without breath-holding. Activity present in the lungs will vary after each inhalation; follow pulmonary count rate during oral inhalation using a gamma camera equipped with a standard collimator (low energy, low/medium resolution). Complete inhalation within 10 minutes of preparation. Patients may breathe room air during administration; do not detach the patient administration set from the patient to prevent residual aerosol from being released. Once pulmonary counts are achieved for imaging, have patient continue exhaling air through the patient administration set for 5 to 6 breaths to trap residual aerosol being exhaled. Also refer to manufacturer's labeling for detailed administration instructions.</p>
<p style="text-indent:-2em;margin-left:2em;">Radiopharmaceutical; use appropriate precautions for handling and disposal.</p></div>
<div class="block admp drugH1Div" id="F58754049"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Radiopharmaceutical; use appropriate precautions for handling and disposal. Use waterproof gloves and effective radiation shielding when handling.</p>
<p style="text-indent:-2em;margin-left:2em;">Inhalation:</p>
<p style="text-indent:-2em;margin-left:4em;">For inhalation use with an FDA-cleared radionuclide rebreathing system for technetium Tc 99m-labeled carbon aerosol (eg, patient administration set from manufacturer) that connects to the Technegas Plus System. Administer while patient is in the supine position. Refer to manufacturer's labeling and user manual for detailed administration instructions.</p></div>
<div class="block use drugH1Div" id="F58703593"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Diagnostic imaging:</b> Visualization of pulmonary ventilation or evaluation of pulmonary embolism when paired with perfusion imaging in adults and pediatric patients ≥6 years of age; use in combination with sodium pertechnetate Tc 99m in the Technegas Plus System.</p></div>
<div class="block mst drugH1Div" id="F58745611"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:0em;margin-left:2em;">Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and health care personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F58739462"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F58739459"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F58745612"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Following maternal inhalation, the reported radiation exposure to the fetus is 0.007 to 0.14 mGy, depending on GA. Adverse fetal effects are not expected following diagnostic procedures with &lt;50 mGy, representing &lt;10 mGy fetal doses.</p>
<p style="text-indent:0em;margin-top:2em;">Refer to the Technetium Tc 99m Sodium Pertechnetate monograph for additional information.</p></div>
<div class="block brc drugH1Div" id="F58745613"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Technetium Tc 99m is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">According to the manufacturer, the decision to breastfeed should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits to the mother. To minimize potential exposure to the breastfed infant, patients can express and discard milk for ≥4 hours after inhalation. Also refer to the Technetium Tc 99m Sodium Pertechnetate monograph for additional information.</p></div>
<div class="block mop drugH1Div" id="F58745625"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Oxygen saturation levels with continuous pulse oximetry; signs of bronchospasm.</p></div>
<div class="block pha drugH1Div" id="F58745618"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Technetium Tc 99m-labeled carbon particles are inhaled and mechanically deposited on the epithelium of ventilated pulmonary bronchioles and alveoli for imaging.</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-Cyclomedica.1">
<a name="Cyclomedica.1"></a>Technegas (technetium Tc 99m-labeled carbon) [prescribing information]. Kingsgrove, New South Wales, Australia: Cyclomedica Australia Pty Ltd; September 2023.</div>
</li></ol></div><div id="topicVersionRevision">Topic 143129 Version 3.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
